Home Health Market Regains Wall Street Losses

The stock market performance of the three largest home health companies continued to rise month over month in March, up 6.21% since February and up 15.0% for the trailing 12-month period. Tracked by healthcare merger and acquisition advisory firm Stoneridge Partners, the index performance of the companies Almost Family (NASDAQ: AFAM), LHC Group (NASDAQ: LHCG) and Amedisys (NASDAQ: AMED) is still down year to date by 1.38%, the Stoneridge home health index shows.

Stoneridge tracks the index against the performance of the S&P 500 index to show the relative health of the home health industry. In its March report, the company noted that for the trailing 24-month period, the index is up more than 101%.

Among the individual company stocks, Amedisys experienced a 10.98-point uptick during the month, while Addus saw a 6.22-point decline. Overall, the index is off more than 5% from its record-high, established in August.

“Over the long term, the home health industry is poised for tremendous growth, driven by an aging U.S. population, patients’ desire for independence, and home health as a cheaper care modality,” Zack’s equity analysts wrote during the month in their coverage of the sector.

NewImage

Written by Elizabeth Ecker

Elizabeth Ecker on EmailElizabeth Ecker on Linkedin
Elizabeth Ecker
Director of Content at Home Health Care News
Curious about all things, when not writing about senior housing topics, Liz is an avid explorer of food. She loves trying new recipes, new restaurants and new ice cream flavors. (Current favorite: Goat cheese with red cherries.)